Warning against New Nicotine Product Infiltrating Schools in New Zealand

Regulations by 2FIRSTS.ai
Apr.17.2024
Warning against New Nicotine Product Infiltrating Schools in New Zealand
New Zealand health professionals warn about the growing presence of ZYN nicotine pouches in schools, posing addiction risks.

According to a report from The New Zealand Herald on April 17th, health professionals in New Zealand are issuing warnings about a new type of nicotine product that is infiltrating schools in New Zealand. ZYN is a brand of smokeless nicotine pouches that is gradually becoming mainstream through social media influencers on platforms such as TikTok and Instagram.

 

This product, based in Sweden, aims to be a replacement for smoking or e-cigarettes to help users quit nicotine.

 

Richard Edwards, professor at the University of Otago and co-director of Aspire2025, expressed concern to the Pioneer Press about the widespread acceptance of these products among young people.

 

While these products may not be as harmful as smoking, they may still be just as addictive, leading to widespread use among young people and creating a widespread dependency on nicotine.

 

Edwards warned that unlike other nicotine pouch brands such as Snus, ZYN brand does not contain tobacco. These nicotine pouches resemble small tea bags and are placed between the lip and gum. They are typically sold in brightly colored cans of 15 to 20, and come in various flavors including berry, coffee, and citrus.

 

New Zealand banned the sale of nicotine pouches in 2020, but importing them from overseas remains legal as long as they are not sold within the country. Despite the ban, The Pioneer newspaper has learned that these products are now making their way into schools nationwide, with reports of students selling them to their peers.

 

However, Sean Teddy, the head of operations and integration at the Ministry of Education, stated that the schools have not raised any concerns about this issue with the department.

 

He emphasized,

 

According to the revised Smoke-free Environments and Regulated Products (Vaping) Amendment Act 2020, smoking or using e-cigarettes on school grounds, kura kaupapa (Māori language schools), early childhood education centers, and kōhanga reo (Māori language immersion preschools) is illegal.

 

In an earlier statement, Deputy Health Minister Casey Costello hinted that she hopes to introduce oral nicotine products, including snus and chewing tobacco, to provide smokers with more and safer alternative smoking options.

 

However, Edwards believes that the introduction of oral nicotine products may not work as expected. Edwards is concerned that these oral nicotine products may not target the intended demographic. He said, "The biggest users of e-cigarettes are young people...we want 50-year-old smokers." He expressed that allowing these products to enter the market without restrictions could lead to more young people becoming dependent on nicotine.

 

Edwards believes that these products should not be introduced unless there are very strong reasons to do so. He suggests that a distribution model similar to that of pharmacies selling only prescription drugs could be implemented, thereby more strictly regulating distribution. However, if these products are widely available in locations such as convenience stores and gas stations, we may see another product being widely used among young people.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23